We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Manufacture and Supply – News and Features

News

Bio Farma Urges OIC Countries to Strengthen Vaccine Cooperation

Bio Farma to make OIC Countries self-reliance in vaccine industry.
News

Roche’s MycoTOOL Receives Acceptance from Canadian Authorities

PCR test reduces time for mycoplasma detection from one month to one day.
News

Vaccine Experts Offer Solutions to Support Vaccine Innovation, Access

Peer-reviewed article in Vaccine offers actions for bringing vaccines to 90% of the world.
News

Pig Disease that Costs Millions Targeted by Genetic Study

A fast mutating virus that affects pig herds and costs pork producers millions of pounds each year is being targeted by scientists.
News

GE Alliance Awarded Contract to Design New Plant-Based Manufacturing Facility in Brazil

New facility for Bio-Manguinhos will use iBio’s plant-based protein expression technology.
News

Vaccine Innovators Convene to Discuss New Technologies

New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Cells, New Vaccines VII: From Protein to Product international scientific conference.
News

Life Technologies Establishes International Influenza Network

Scientists at leading public health agencies and research institutes collaborate to develop faster, more reliable flu subtyping methods.
News

Frost & Sullivan Predicts Growth for the European Vaccines Market

Technology innovation and increasing focus on new vaccine development are likely to revolutionize the vaccine industry from prophylactic to therapeutic vaccines.
News

Paragon Bioservices Acquires Systems for Use in Vaccine and Protein Manufacturing

Company accelerates the development and manufacturing of cell-based VLP-type vaccines using the MaxCyte Flow Electroporation Technology Platform.
News

Designer Bacteria May Lead to Better Vaccines

Researchers have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
Advertisement